Skip to main content

Table 1 Clinical and demographic data of the studied groups

From: Impact of resilience on disease severity and psychiatric comorbidities in patients with fibromyalgia

 

Case group

N = 101

Control group

N = 63

P value

Age

43.12 ± 10.57

39.86 ± 5.8

0.1541

Females (%)

101 (100%)

63 (100%)

 

Workers (%)

95 (94.1)

63 (100%)

0.0492

Does not work (%)

6 (5.1%)

0

 

Low education (%)

7 (6.9%)

0

0.022

Medium education (%)

54 (53.5%)

27 (42.9%)

 

High education (%)

40 (39.5%)

36 (57.1%)

 

Rural

32 (31.7%)

21 (33.3%)

0.8292

Urban

69 (68.3%)

42 (66.7%)

 

Married

81 (80.2%)

54 (85.7%)

0.3682

Non-married

20 (19.8%)

9 (14.3%)

 

Symptoms duration

3.6040 ± 2.349

  

Physical impairment

5.93198 ± 1.49

  

Days feel good

6.3189 ± 2.067

  

Work missed days

6.2253 ± 2.812

  

Job ability

7.47 ± 1.884

  

VAS pain

7.45 ± 1.48

  

VAS fatigue

7.49 ± 1.712

  

VAS morning tiredness

6.74 ± 2.274

  

VAS stiffness

6.36 ± 2.516

  

VAS anxiety

6.30 ± 3.084

  

VAS depression

5.80 ± 3.184

  

FIQ total score

65.910 ± 16.38

  

FIQ less than 50(%)

24 (38.72%)

  

FIQ 50 to less than 70 (%)

26 (23.8%)

  

FIQ 70 or more (%)

51 (25.7%)

  

Resilience score (%)

60.38 ± 15.677

68.3 ± 7.32

0.0111

Major depressive disorder (%)

50 (49.5%)

5 (9.1%)

0.00012

Persistent Depressive disorder (%)

58 (57.4%)

3 (5.5%)

0.00012

Generalized anxiety disorder (%)

56 (55.4%)

11 (20%)

0.00012

Low suicide risk (%)

93 (92.1%)

63 (100%)

0.00012

Medium suicide risk (%)

3 (3%)

  

High suicidal risk (%)

5 (5%)

  
  1. All variables are expressed as mean ± standard deviation except otherwise indicated. P value is significant if ≤ 0.005, 1 = Mann–Whitney U test, 2 = Pearson chi-square, N = number of patients, Std. Deviation = standard deviation, FIQ = Fibromyalgia Impact Questionnaire, VAS = visual analogue scale